Evidence map›Paper›PMID 23305740›Full record

ArticleBlood2013

Intrathymic progenitor cell transplantation across histocompatibility barriers results in the persistence of early thymic progenitors and T-cell differentiation.

Stéphanie C de Barros, Rita Vicente, Karim Chebli, Chantal Jacquet, Valérie S Zimmermann, Naomi Taylor

Abstract readEvaluation Study
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stéphanie C de BarrosInstitut de Génétique Moléculaire de Montpellier, UMR5535CNRS, Université Montpellier 2, Université Montpellier 1, Montpellier, France.
Rita Vicente
Karim Chebli
Chantal Jacquet
Valérie S Zimmermann
Naomi Taylor

Funding

ZAP-70 Deficiency: A model for gene therapy studiesR01AI059349 · NIAID · CNRS DELEGATION LANGUEDOC-ROUSSILLON · PI TAYLOR, NAOMI · 2007 to 2010
$812k
NIAID NIH HHS R01 AI059349NIAID NIH HHS R01AI059349
6 · The paper itself

Abstract

Donor hematopoietic stem cells (HSCs) can correct T-cell deficiencies in patients with severe combined immunodeficiency by replacing resident thymus cells. However, as those progenitors that naturally migrate to the thymus are not capable of supporting long-term thymopoiesis, a successful transplant is thought to require the ongoing migration of donor progenitors. We previously showed that the forced intrathymic administration of histocompatible HSCs can sustain long-term thymopoiesis in ZAP-70-immunodeficient mice. However, it is not known whether T-cell reconstitution across histocompatibility barriers is modulated by intrathymic vs intravenous administration of HSCs. In the absence of conditioning, long-term thymopoiesis by semiallogeneic progenitors was detected in mice transplanted via the intrathymic, but not the intravenous, route. In intrathymic-transplanted mice, ongoing thymopoiesis was associated with a 10-fold higher level of early thymic progenitors (ETPs). The enhanced reconstitution capacity of these intrathymic-derived ETPs was corroborated by their significantly augmented myeloid lineage potential compared with endogenous ETPs. Notably, though, myeloablative conditioning resulted in a reduced expansion of intrathymic-administered donor ETPs. Thus, in the absence of conditioning, the forced thymic entry of HSCs results in a sustained T-cell development across histocompatibility barriers, highlighting the capacity of the thymus to support cells with long-term renewal potential.

Indexed as

Graft SurvivalThymus GlandAnimalsCell DifferentiationCells, CulturedHematopoiesisHematopoietic Stem Cell TransplantationHistocompatibilityHistocompatibility TestingInfusions, IntravenousLymphoid Progenitor CellsMiceMice, Inbred C57BLMice, Inbred CBAMice, KnockoutSevere Combined ImmunodeficiencyZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID23305740
PMCPMC3596972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.